DLQAX
Price
$11.01
Change
-$0.42 (-3.67%)
Updated
Apr 10 closing price
Net Assets
170.9M
GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
Ad is loading...

DLQAX vs GFACX

Header iconDLQAX vs GFACX Comparison
Open Charts DLQAX vs GFACXBanner chart's image
BNY Mellon Large Cap Equity A
Price$11.01
Change-$0.42 (-3.67%)
VolumeN/A
Net Assets170.9M
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
DLQAX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLQAX vs. GFACX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLQAX is a Buy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. DLQAX (171M). DLQAX pays higher dividends than GFACX: DLQAX (0.23) vs GFACX (0.00). DLQAX was incepted earlier than GFACX: DLQAX (33 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than DLQAX (1.09). DLQAX is a more actively managed with annual turnover of: 39.80 vs. GFACX (25.00). GFACX has a lower initial minimum investment than DLQAX: GFACX (250) vs DLQAX (1000). GFACX annual gain was more profitable for investors over the last year : -3.95 vs. DLQAX (-24.08). GFACX return over 5 years is better than : 40.74 vs. DLQAX (-33.88).
DLQAXGFACXDLQAX / GFACX
Total Expense Ratio1.001.3674%
Annual Report Gross Expense Ratio1.091.3680%
Fund Existence33 years24 years-
Gain YTD-9.401-7.732122%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets171M272B0%
Annual Yield % from dividends0.230.00-
Returns for 1 year-24.08-3.95609%
Returns for 3 years-50.014.35-1,151%
Returns for 5 years-33.8840.74-83%
Returns for 10 years-31.3238.82-81%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings